Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 74 Breast Neoplasms 70 Rectal Neoplasms 51 Stomach Neoplasms 45 Glioblastoma 45 Esophageal Neoplasms 42 Colorectal Neoplasms 37 Lung Neoplasms 35 Brain Neoplasms 35 Squamous Cell Carcinoma of Head and Neck 32 Pancreatic Neoplasms 31 Glioma 27 Neoplasms 26 Sarcoma 24 Neoplasm Metastasis 23 Astrocytoma 22 Head and Neck Neoplasms 21 Carcinoma, Hepatocellular 19 Esophageal Squamous Cell Carcinoma 16 Colonic Neoplasms 16 Recurrence 15 Ovarian Neoplasms 15 Melanoma 15 Gliosarcoma 15 Central Nervous System Neoplasms 15 Urinary Bladder Neoplasms 13 Oligodendroglioma 13 Uterine Cervical Neoplasms 12 Adenocarcinoma Of Esophagus 12 Prostatic Neoplasms 11

Interventions

pembrolizumab 29 avelumab 21 Nivolumab 20 Ipilimumab 10 Radiotherapy 9 Cyclophosphamide 9 atezolizumab 8 cemiplimab 7 fludarabine 6 Specimen Handling 6 durvalumab 5 aldesleukin 5 Radiation 5 Magnetic Resonance Spectroscopy 5 Interleukin-2 5 Biopsy 5 talimogene laherparepvec 4 ALT-803 4 poly ICLC 3 Radiosurgery 3 Etoposide 3 Cisplatin 3 Carboplatin 3 CTLA-4 Antigen 3 Bevacizumab 3 prednylidene 2 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 domatinostat 2 deltacortene 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Surgical Procedures, Operative × Clear all

NCT05253144 2024-05-08

Rational-MCC

University of Birmingham

Phase NA Completed

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡